Wooree Bio Co.Ltd
Wooree Bio Co.,Ltd, together with its subsidiaries, engages in the production and sale of flexible circuit boards in South Korea. The company also offers LED packages and modules; surface mounting technology products; separators for secondary batteries; backlight parts for thin film transistor-liquid crystal displays; sells and assembles TVs; and TV and LCD monitor components. In addition, it pro… Read more
Wooree Bio Co.Ltd (082850) - Total Assets
Latest total assets as of September 2025: ₩782.08 Billion KRW
Based on the latest financial reports, Wooree Bio Co.Ltd (082850) holds total assets worth ₩782.08 Billion KRW as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Wooree Bio Co.Ltd - Total Assets Trend (2008–2024)
This chart illustrates how Wooree Bio Co.Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Wooree Bio Co.Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Wooree Bio Co.Ltd's total assets of ₩782.08 Billion consist of 66.5% current assets and 33.6% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩69.48 Billion | 11.4% |
| Accounts Receivable | ₩163.72 Billion | 26.9% |
| Inventory | ₩104.60 Billion | 17.2% |
| Property, Plant & Equipment | ₩186.67 Billion | 30.6% |
| Intangible Assets | ₩3.11 Billion | 0.5% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2008–2024)
This chart illustrates how Wooree Bio Co.Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Wooree Bio Co.Ltd's current assets represent 66.5% of total assets in 2024, an increase from 0.0% in 2008.
- Cash Position: Cash and equivalents constituted 11.4% of total assets in 2024, up from 9.1% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 2.0% in 2008.
- Asset Diversification: The largest asset category is property, plant & equipment at 30.6% of total assets.
Wooree Bio Co.Ltd Competitors by Total Assets
Key competitors of Wooree Bio Co.Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Fidelix Co. Ltd
KQ:032580
|
Korea | ₩54.45 Billion |
|
UNISEM Co. Ltd
KQ:036200
|
Korea | ₩275.09 Billion |
|
Cloud Air Co.Ltd
KQ:036170
|
Korea | ₩157.42 Billion |
|
JUSUNG ENGINEERING Co. Ltd
KQ:036930
|
Korea | ₩871.61 Billion |
|
Lumens Co. Ltd
KQ:038060
|
Korea | ₩152.88 Billion |
|
meerecompany Incorporated
KQ:049950
|
Korea | ₩127.08 Billion |
|
I&C Technology Co. Ltd
KQ:052860
|
Korea | ₩53.55 Billion |
|
KMH Hitech Co. Ltd
KQ:052900
|
Korea | ₩205.49 Billion |
Wooree Bio Co.Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Wooree Bio Co.Ltd generates 2.03x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Wooree Bio Co.Ltd generates $ 0.78 in net profit.
Wooree Bio Co.Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.25 | 1.43 | 1.02 |
| Quick Ratio | 1.07 | 1.07 | 0.81 |
| Cash Ratio | 0.00 | 0.24 | 0.00 |
| Working Capital | ₩117.67 Billion | ₩ 138.09 Billion | ₩ 11.59 Billion |
Wooree Bio Co.Ltd - Advanced Valuation Insights
This section examines the relationship between Wooree Bio Co.Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.42 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 4.1% |
| Total Assets | ₩609.82 Billion |
| Market Capitalization | $38.92 Million USD |
Valuation Analysis
Below Book Valuation: The market values Wooree Bio Co.Ltd's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Wooree Bio Co.Ltd's assets grew by 4.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Wooree Bio Co.Ltd (2008–2024)
The table below shows the annual total assets of Wooree Bio Co.Ltd from 2008 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩609.82 Billion | +4.15% |
| 2023-12-31 | ₩585.54 Billion | +4.76% |
| 2022-12-31 | ₩558.94 Billion | -15.86% |
| 2021-12-31 | ₩664.33 Billion | +2.82% |
| 2020-12-31 | ₩646.10 Billion | +5.92% |
| 2019-12-31 | ₩609.99 Billion | +0.80% |
| 2018-12-31 | ₩605.18 Billion | -1.34% |
| 2017-12-31 | ₩613.37 Billion | -25.00% |
| 2016-12-31 | ₩817.88 Billion | -10.14% |
| 2015-12-31 | ₩910.18 Billion | +13.64% |
| 2014-12-31 | ₩800.92 Billion | +15.21% |
| 2013-12-31 | ₩695.16 Billion | +58.09% |
| 2012-12-31 | ₩439.73 Billion | +7.02% |
| 2011-12-31 | ₩410.89 Billion | -43.78% |
| 2010-12-31 | ₩730.85 Billion | +30.57% |
| 2009-12-31 | ₩559.75 Billion | +39.66% |
| 2008-12-31 | ₩400.79 Billion | -- |